{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:06:22Z","timestamp":1792008382225,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T00:00:00Z","timestamp":1194393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1038\/sj.npp.1301528","type":"journal-article","created":{"date-parts":[[2007,11,7]],"date-time":"2007-11-07T12:41:11Z","timestamp":1194439271000},"page":"1239-1251","source":"Crossref","is-referenced-by-count":226,"title":["Mechanisms of Dopaminergic and Serotonergic Neurotransmission in Tourette Syndrome: Clues from an In Vivo Neurochemistry Study with PET"],"prefix":"10.1038","volume":"33","author":[{"given":"Dean F","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R","family":"Bra\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey S","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Schretlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayon","family":"Nandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marika A","family":"Maris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohab","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Rousset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Gjedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony A","family":"Grace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,11,7]]},"reference":[{"key":"BF1301528_CR1","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1212\/01.WNL.0000076181.39162.FC","volume":"61","author":"RL Albin","year":"2003","unstructured":"Albin RL, Koeppe RA, Bohnen NI, Nichols TE, Meyer P, Wernette K et al (2003). Increased ventral striatal monoaminergic innervation in Tourette syndrome. Neurology 61: 310\u2013315.","journal-title":"Neurology"},{"key":"BF1301528_CR2","unstructured":"American Psychiatric Association (2004). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Text revision (DSM-IV-TM\u2122), American Psychiatric Association: Washington, DC."},{"key":"BF1301528_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1176\/jnp.11.1.71","volume":"11","author":"MH Baumann","year":"1999","unstructured":"Baumann MH, Danos P, Krell D, Diekmann S, Leschinger A, Stauch R et al (1999). Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study. J Neuropsychiatry Clin Neurosci 11: 71\u201378.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"BF1301528_CR4","first-page":"29","volume":"57","author":"RD Bruun","year":"1996","unstructured":"Bruun RD, Budman CL (1996). Risperidone as a treatment for Tourette's syndrome. J Clin Psychiatry 57: 29\u201331.","journal-title":"J Clin Psychiatry"},{"key":"BF1301528_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ana.410060109","volume":"6","author":"IJ Butler","year":"1979","unstructured":"Butler IJ, Koslow SH, Seifert Jr WE, Caprioli RM, Singer HS (1979). Biogenic amine metabolism in Tourette syndrome. Ann Neurol 6: 37\u201339.","journal-title":"Ann Neurol"},{"key":"BF1301528_CR6","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/ajmg.1320360410","volume":"36","author":"DE Comings","year":"1990","unstructured":"Comings DE (1990). Blood serotonin and tryptophan in Tourette Syndrome. Am J Med Genet 36: 418\u2013430.","journal-title":"Am J Med Genet"},{"key":"BF1301528_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0020-708X(85)90083-3","volume":"36","author":"E Ehrin","year":"1985","unstructured":"Ehrin E, Farde L, de Paulis T, Eriksson L, Greitz T, Johnstrom P et al (1985). Preparation of 11C-labelled Raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey. Int J Appl Radiat Isot 36: 269\u2013273.","journal-title":"Int J Appl Radiat Isot"},{"key":"BF1301528_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00004583-199901000-00024","volume":"38","author":"M Ernst","year":"1999","unstructured":"Ernst M, Zametkin AJ, Jons PH, Matochik JA, Pascualvaca D, Cohen RM (1999). High presynaptic dopaminergic activity in children with Tourette's disorder. J Am Acad Child Adolesc Psychiatry 38: 86\u201394.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1301528_CR9","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/jcbfm.1989.98","volume":"9","author":"L Farde","year":"1989","unstructured":"Farde L, Eriksson L, Blomquist G, Halldin C (1989). Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET: a comparison to the equilibrium analysis. J Cereb Blood Flow Metab 9: 696\u2013708.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF1301528_CR10","volume-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV)","author":"MB First","year":"1994","unstructured":"First MB, Spitzer RL, Gibbon M, Williams JBW (1994). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). American Psychiatric Press: Washington, DC."},{"key":"BF1301528_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-642-55539-8_7","volume-title":"Molecular Nuclear Medicine,","author":"A Gjedde","year":"2003","unstructured":"Gjedde A (2003). Modeling metabolite and tracer kinetics. In: Feinendegen LE, Shreeve WW, Eckelman WC, Bahk Y-W, Wagner Jr HN (eds). Molecular Nuclear Medicine, Chapter 7. Springer-Verlag: Berlin, Heidelberg. pp 121\u2013169."},{"key":"BF1301528_CR12","doi-asserted-by":"publisher","first-page":"A44","DOI":"10.1016\/S1053-8119(18)31913-X","volume":"7","author":"A Gjedde","year":"1998","unstructured":"Gjedde A, Wong DF (1998). No acute effect of amphetamine on dopamine receptor binding potential in healthy subjects or patients in schizophrenia. NeuroImage 7: A44 (abstract).","journal-title":"NeuroImage"},{"key":"BF1301528_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1001\/archpsyc.1989.01810110054008","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Delgado P, Heninger GR et al (1989a). The Yale\u2013Brown Obsessive Compulsive Scale. II. Validity. Arch Gen Psychiatry 46: 1012\u20131016.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301528_CR14","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","volume":"46","author":"WK Goodman","year":"1989","unstructured":"Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL et al (1989b). The Yale\u2013Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Arch Gen Psychiatry 46: 1006\u20131011.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301528_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0306-4522(91)90196-U","volume":"41","author":"AA Grace","year":"1991","unstructured":"Grace AA (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41: 1\u201324.","journal-title":"Neuroscience"},{"key":"BF1301528_CR16","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01245228","volume":"91","author":"AA Grace","year":"1993","unstructured":"Grace AA (1993). Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm 91: 111\u2013134.","journal-title":"J Neural Transm"},{"key":"BF1301528_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/0376-8716(94)01066-T","volume":"37","author":"AA Grace","year":"1995","unstructured":"Grace AA (1995). The tonic\/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia function. Drug Alcohol Depend 37: 111\u2013129.","journal-title":"Drug Alcohol Depend"},{"key":"BF1301528_CR18","first-page":"217","volume-title":"ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W (1976). ECDEU Assessment Manual for Psychopharmacology Revised, DHEW Publication No. (ADM) 76-338 US Department of Health, Education, and Welfare: Rockville, MD, 217\u2013222."},{"key":"BF1301528_CR19","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1017\/S1461145706006559","volume":"10","author":"S Haugbol","year":"2007","unstructured":"Haugbol S, Pinborg LH, Regeur L, Hansen ES, Bolwig TG, Nielsen FA et al. (2007). Cerebral 5-HT2A receptor binding is increased in patients with Tourette's syndrome. Int J Neuropsychopharmacol 10: 245\u2013252.","journal-title":"Int J Neuropsychopharmacol"},{"key":"BF1301528_CR20","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1212\/WNL.51.4.1069","volume":"51","author":"A Heinz","year":"1998","unstructured":"Heinz A, Knable MB, Wolf SS, Jones DW, Gorey JG, Hyde TM et al (1998). Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity. Neurology 51: 1069\u20131074.","journal-title":"Neurology"},{"key":"BF1301528_CR21","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1097\/01.WCB.0000085441.37552.CA","volume":"23","author":"M Ichise","year":"2003","unstructured":"Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H et al (2003). Linearized reference tissue oparametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 23: 1096\u20131112.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF1301528_CR22","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.WCB.0000038000.34930.4E","volume":"22","author":"M Ichise","year":"2002","unstructured":"Ichise M, Toyama H, Innis RB, Carson RE (2002). Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 22: 1271\u20131281.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF1301528_CR23","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/cne.10312","volume":"450","author":"C Karachi","year":"2002","unstructured":"Karachi C, Francois C, Parain K, Bardinet E, Tande D, Hirsch E et al (2002). Three-dimensional cartography of functional territories in the human striatopallidal complex by using calbindin immunoreactivity. J Comp Neurol 450: 122\u2013134.","journal-title":"J Comp Neurol"},{"key":"BF1301528_CR24","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammerstma","year":"1996","unstructured":"Lammerstma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. NeuroImage 4: 153\u2013158.","journal-title":"NeuroImage"},{"key":"BF1301528_CR25","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0006-3223(99)00067-0","volume":"46","author":"M Laruelle","year":"1999","unstructured":"Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999). Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46: 56\u201372.","journal-title":"Biol Psychiatry"},{"key":"BF1301528_CR26","doi-asserted-by":"publisher","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","volume":"93","author":"M Laruelle","year":"1996","unstructured":"Laruelle M, Abi-Dargham A, Van Dyck C, Gil R, D'Souza C, Erdos J et al (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci USA 93: 9235\u20139240.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1301528_CR27","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1016\/0024-3205(84)90435-1","volume":"35","author":"JF Leckman","year":"1984","unstructured":"Leckman JF, Anderson GM, Cohen DJ, Ort S, Harcherik DF, Hoder EL et al (1984). Whole blood serotonin and tryptophan levels in Tourette's disorder: effects of acute and chronic clonidine treatment. Life Sci 35: 2497\u20132503.","journal-title":"Life Sci"},{"key":"BF1301528_CR28","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J et al (1989). The Yale Global Tic Severity Scale: initial testing of a clinician rated scale of tic severity. J Am Acad Child Adolesc Psychiatry 28: 566\u2013573.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"BF1301528_CR29","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1038\/sj.npp.1300963","volume":"31","author":"DJ Lodge","year":"2006","unstructured":"Lodge DJ, Grace AA (2006). The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology 31: 1356\u20131361.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301528_CR30","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/00004647-199609000-00008","volume":"16","author":"J Logan","year":"1996","unstructured":"Logan J, Fowler JS, Volkow ND, Wang GJ, Ding YS, Alexoff D (1996). Distribution volume ratios without blood sampling from graphical analysis of PET data. J Cereb Blood Flow Metab 16: 834\u2013840.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF1301528_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1176\/ajp.152.9.1359","volume":"152","author":"RT Malison","year":"1995","unstructured":"Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP et al (1995). [123I]\u03b2-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder. Am J Psychiatry 152: 1359\u20131361.","journal-title":"Am J Psychiatry"},{"key":"BF1301528_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.WCB.0000048520.34839.1A","volume":"23","author":"D Martinez","year":"2003","unstructured":"Martinez D, Slifstein M, Broft A, Mawlawi T, Hwang DR, Huang YY et al (2003). Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23: 285\u2013300.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF1301528_CR33","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/sj.npp.1300736","volume":"30","author":"UD McCann","year":"2005","unstructured":"McCann UD, Szabo Z, Seckin E, Rosenblatt P, Mathews WB, Ravert HT et al (2005). Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB. Neuropsychopharmacology 30: 1741\u20131750.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301528_CR34","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","volume":"57","author":"CJ McDougle","year":"2000","unstructured":"McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH (2000). A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 57: 794\u2013801.","journal-title":"Arch Gen Psychiatry"},{"key":"BF1301528_CR35","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1006\/nimg.1999.0431","volume":"9","author":"JH Meyer","year":"1999","unstructured":"Meyer JH, Gunn RN, Myers R, Grasby PM (1999). Assessment of spatial normalization of PET ligand images using ligand-specific templates. NeuroImage 9: 545\u2013553.","journal-title":"NeuroImage"},{"key":"BF1301528_CR36","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.neulet.2005.05.031","volume":"385","author":"KR Muller-Vahl","year":"2005","unstructured":"Muller-Vahl KR, Meyer GJ, Knapp WH, Emrich HM, Gielow P, Brucke T et al (2005). Serotonin transporter binding in Tourette syndrome. Neurosci Lett 385: 120\u2013125.","journal-title":"Neurosci Lett"},{"key":"BF1301528_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1080\/00223989709603843","volume":"131","author":"JB Murray","year":"1997","unstructured":"Murray JB (1997). Psychophysiological aspects of Tourette's syndrome. J Psychol 131: 615\u2013626.","journal-title":"J Psychol"},{"key":"BF1301528_CR38","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0006-8993(94)90263-1","volume":"634","author":"P O'Donnell","year":"1994","unstructured":"O'Donnell P, Grace AA (1994). Tonic D2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Res 634: 105\u2013112.","journal-title":"Brain Res"},{"key":"BF1301528_CR39","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","volume":"10","author":"JE Overall","year":"1962","unstructured":"Overall JE, Gorham DR (1962). The Brief Psychiatric Rating Scale. Psychol Rep 10: 799\u2013812.","journal-title":"Psychol Rep"},{"key":"BF1301528_CR40","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/00004850-200015050-00007","volume":"15","author":"C Pfanner","year":"2000","unstructured":"Pfanner C, Marazziti D, Dell'Osso L, Presta S, Gemignani A, Milanfranchi A et al (2000). Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study. Int Clin Psychopharmacol 15: 297\u2013301.","journal-title":"Int Clin Psychopharmacol"},{"key":"BF1301528_CR41","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1016\/S0006-3223(03)00183-5","volume":"54","author":"O Pogarell","year":"2003","unstructured":"Pogarell O, Hamann C, Popperl G, Juckel G, Chouker M, Zaudig M et al (2003). Elevated brain serotonin transporter availability in patients with obsessive-compulsive disorder. Biol Psychiatry 54: 1406\u20131413.","journal-title":"Biol Psychiatry"},{"key":"BF1301528_CR42","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0893-133X(01)00333-5","volume":"26","author":"G Porras","year":"2002","unstructured":"Porras G, Di Matteo V, Fracasso C, Lucas G, De Deurwaerdere P, Caccia S et al (2002). 5-HT2A and 5-HT2C\/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropsychopharmacology 26: 311\u2013324.","journal-title":"Neuropsychopharmacology"},{"key":"BF1301528_CR43","doi-asserted-by":"publisher","first-page":"11651","DOI":"10.1073\/pnas.91.24.11651","volume":"91","author":"J Reith","year":"1994","unstructured":"Reith J, Benkelfat C, Sherwin A, Yasuhara Y, Kuwabara H, Andermann F et al (1994). Elevated DOPA decarboxylase activity in living brain of patients with psychosis. Proc Natl Acad Sci USA 91: 11651\u201311654.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF1301528_CR44","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","volume":"3","author":"L Scahill","year":"2006","unstructured":"Scahill L, Erenberg G, Berlin Jr CM, Budman C, Coffey BJ, Jankovic J et al (2006). Tourette Syndrome Association Medical Advisory Board: Practice Committee Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx 3: 192\u2013206.","journal-title":"NeuroRx"},{"key":"BF1301528_CR45","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1046\/j.1471-4159.1994.62041382.x","volume":"62","author":"CJ Schmidt","year":"1994","unstructured":"Schmidt CJ, Sullivan CK, Fadayel GM (1994). Blocakde of striatal 5-HT2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-metylenedioxymethamphetamine. J Neurochem 62: 1382\u20131389.","journal-title":"J Neurochem"},{"key":"BF1301528_CR46","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/S0006-3223(00)00945-8","volume":"48","author":"RD Shytle","year":"2000","unstructured":"Shytle RD, Silver AA, Sanberg PR (2000). Comorbid bipolar disorder in Tourette's syndrome responds to the nicotinic receptor antagonist mecamylamine (Inversine). Biol Psychiatry 48: 1028\u20131031.","journal-title":"Biol Psychiatry"},{"key":"BF1301528_CR47","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/cap.2000.10.59","volume":"10","author":"AA Silver","year":"2000","unstructured":"Silver AA, Shytle RD, Sanberg PR (2000). Mecamylamine in Tourette's syndrome: a two-year retrospective case study. J Child Adolesc Psychopharmacol 10: 59\u201368.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"BF1301528_CR48","first-page":"58","volume":"16","author":"R Silvestri","year":"1994","unstructured":"Silvestri R, Raffaele M, De Domenico P, Tisano A, Lagana A, Di Perri R (1994). Serotoninergic agents in the treatment of Gilles de la Tourette's syndrome. Acta Neurol 16: 58\u201363.","journal-title":"Acta Neurol"},{"key":"BF1301528_CR49","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/S0006-3223(03)00544-4","volume":"54","author":"HB Simpson","year":"2003","unstructured":"Simpson HB, Lombardo I, Slifstein M, Huang HY, Hwang DR, Abi-Dargham A et al (2003). Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652. Biol Psychiatry 54: 1414\u20131421.","journal-title":"Biol Psychiatry"},{"key":"BF1301528_CR50","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11910-001-0016-8","volume":"1","author":"HS Singer","year":"2001","unstructured":"Singer HS (2001). The treatment of tics. Curr Neurol Neurosci Rep 1: 195\u2013202.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"BF1301528_CR51","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ana.410120408","volume":"12","author":"HS Singer","year":"1982","unstructured":"Singer HS, Butler IJ, Tune LE, Seifert Jr WF, Coyle JT (1982). Dopaminergic dysfunction in Tourette syndrome. Ann Neurol 12: 361\u2013366.","journal-title":"Ann Neurol"},{"key":"BF1301528_CR52","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.43.5.950","volume":"43","author":"HS Singer","year":"1993","unstructured":"Singer HS, Reiss AL, Brown JE, Aylward EH, Shih B, Chee E et al (1993). Volumetric MRI changes in basal ganglia of children with Tourettes-syndrome. Neurology 43: 950\u2013956.","journal-title":"Neurology"},{"key":"BF1301528_CR53","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1176\/appi.ajp.159.8.1329","volume":"159","author":"HS Singer","year":"2002","unstructured":"Singer HS, Szymanski S, Giuliano J, Yokoi F, Dogan AS, Brasic JR et al (2002). Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry 159: 1329\u20131336.","journal-title":"Am J Psychiatry"},{"key":"BF1301528_CR54","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1002\/ana.410300408","volume":"30","author":"HS Singer","year":"1991","unstructured":"Singer HS, Hahn IH, Moran TH (1991). Abnormal dopamine uptake sites in postmortem striatum from patients with Tourette's syndrome. Ann Neurol 30: 558\u2013562.","journal-title":"Ann Neurol"},{"key":"BF1301528_CR55","first-page":"A29","volume":"5","author":"T S\u00f6lling","year":"1997","unstructured":"S\u00f6lling T, Brust P, Cunningham VJ, Wong DF, Gjedde A (1997). True equilibrium bolus estimation (TREMBLE) confirms rapid transient equilibrium. NeuroImage 5: A29.","journal-title":"NeuroImage"},{"key":"BF1301528_CR56","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00406-004-0489-y","volume":"254","author":"K Stengler-Wenzke","year":"2004","unstructured":"Stengler-Wenzke K, Muller U, Angermeyer MC, Sabri O, Hesse S (2004). Reduced serotonin transporter-availability in obsessive-compulsive disorder (OCD). Eur Arch Psychiatry Clin Neurosci 254: 252\u2013255.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BF1301528_CR57","first-page":"678","volume":"43","author":"Z Szabo","year":"2002","unstructured":"Szabo Z, McCann UD, Wilson AA, Scheffel U, Owonikoko T, Mathews WB et al (2002). Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditions. J Nucl Med 43: 678\u2013692.","journal-title":"J Nucl Med"},{"key":"BF1301528_CR58","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/0006-3223(92)90280-D","volume":"31","author":"A Weizman","year":"1992","unstructured":"Weizman A, Mandel A, Barber Y, Weitz R, Cohen A, Mester R et al (1992). Decreased platelet imipramine binding in Tourette syndrome children with obsessive-compulsive disorder. Biol Psychiatry 31: 705\u2013711.","journal-title":"Biol Psychiatry"},{"key":"BF1301528_CR59","volume-title":"Attention-Deficit Hyperactivity Disorder in Adults","author":"PH Wender","year":"1995","unstructured":"Wender PH (1995). Attention-Deficit Hyperactivity Disorder in Adults. Oxford University Press: New York."},{"key":"BF1301528_CR60","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1523\/JNEUROSCI.22-01-00294.2002","volume":"22","author":"AR West","year":"2002","unstructured":"West AR, Grace AA (2002). Opposite influences of endogenous dopamine D1 and D2 receptors activation on activity states and electrophysiological properties of striatal neurons: studies combining in vivo intracellular recordings and reverse microdialysis. J Neurosci 22: 294\u2013304.","journal-title":"J Neurosci"},{"key":"BF1301528_CR61","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1046\/j.1471-4159.2002.01005.x","volume":"82","author":"RM Wightman","year":"2002","unstructured":"Wightman RM, Robinson DR (2002). Transient changes in mesolimbic dopamine and their association with \u2018reward\u2019. J Neurochem 82: 721\u2013735.","journal-title":"J Neurochem"},{"key":"BF1301528_CR62","first-page":"182P","volume":"48","author":"DF Wong","year":"2005","unstructured":"Wong DF, Brasic JR, Kuwabara H, Zhou Y, Schretlen D, Kumar A et al (2005). Abnormalities of dopamine and serotonin neuroreceptors documented with PET in Tourette syndrome. J Nucl Med 48: 182P (abstract).","journal-title":"J Nucl Med"},{"key":"BF1301528_CR63","first-page":"1243","volume":"38","author":"DF Wong","year":"1997","unstructured":"Wong DF, Singer HS, Brandt J, Shaya E, Chen C, Brown J et al (1997). D2-like dopamine receptor density in Tourette syndrome measured by PET. J Nucl Med 38: 1243\u20131247.","journal-title":"J Nucl Med"},{"key":"BF1301528_CR64","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/B978-012161340-2\/50071-8","volume-title":"Quantitative Functional Brain Imaging with Positron Emission Tomography,","author":"DF Wong","year":"1998","unstructured":"Wong DF, Solling T, Yokoi F, Gjedde A (1998). Quantification of extracellular dopamine release in schizophrenia and cocaine use by means of TREMBLE. In: Carson RE, Herscovitch P, Daube-Witherspoon ME (eds). Quantitative Functional Brain Imaging with Positron Emission Tomography, 1st edn. Academic Press: San Diego, California. pp 463\u2013468."},{"key":"BF1301528_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/syn.890150205","volume":"15","author":"DF Wong","year":"1993","unstructured":"Wong DF, Yung B, Dannals RF, Shaya EK, Ravert HT, Chen CA et al (1993). In vivo imaging of baboon and human dopamine transporters by positron emission tomography, using [11C]WIN 35,428. Synapse 15: 130\u2013142.","journal-title":"Synapse"},{"issue":"Suppl 5","key":"BF1301528_CR66","first-page":"395P","volume":"45","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Brasic J, Dogan AS, Ye W, Crabb AH, Hilton J et al (2004a). A robust parametric imaging algorithm to quantify serotonin receptor and transporter binding in human brain using 11C-MDL 100,907 and (+)11C-MCN 5652 dynamic PET. J Nucl Med 45 (Suppl 5): 395P\u2013396P (abstract).","journal-title":"J Nucl Med"},{"key":"BF1301528_CR67","first-page":"S91","volume":"16","author":"Y Zhou","year":"2002","unstructured":"Zhou Y, Brasic J, Endres CJ, Kuwabara H, Kimes A, Contoreggi C et al (2002a). Binding potential image based statistical mapping for detection of dopamine release by [11C]raclopride dynamic PET. NeuroImage 16: S91.","journal-title":"NeuroImage"},{"key":"BF1301528_CR68","first-page":"T98","volume":"22","author":"Y Zhou","year":"2004","unstructured":"Zhou Y, Brasic JR, Ye WG, Dogan AS, Hilton J, Singer HS et al (2004b). Quantification of cerebral serotonin binding in normal controls and subjects with Tourette's syndrome using [C-11]MDL 100,907 and (+)[C-11]McN 5652 dynamic PET with parametric imaging approach. NeuroImage 22: T98\u2013T99.","journal-title":"NeuroImage"},{"key":"BF1301528_CR69","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/S1053-8119(03)00017-X","volume":"18","author":"Y Zhou","year":"2003","unstructured":"Zhou Y, Endres CJ, Brasic JR, Huang SC, Wong DF (2003). Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. NeuroImage 18: 975\u2013989.","journal-title":"NeuroImage"},{"key":"BF1301528_CR70","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1006\/nimg.2001.1021","volume":"15","author":"Y Zhou","year":"2002","unstructured":"Zhou Y, Huang SC, Bergsneider M, Wong DF (2002b). Improved parametric image generation using spatial-temporal analysis of dynamic PET studies. NeuroImage 15: 697\u2013707.","journal-title":"NeuroImage"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/1301528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301528","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/1301528.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T06:56:11Z","timestamp":1684220171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1301528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,7]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["BF1301528"],"URL":"https:\/\/doi.org\/10.1038\/sj.npp.1301528","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,7]]}}}